Cargando…
Colchicine intolerance in FMF patients and primary obstacles for optimal dosing
BACKGROUND/AIM: Colchicine is the mainstay of treatment in FMF. However, in daily practice it is not easy to maintain effective colchicine doses in a substantial number of patients due to its side effects. In this study, we aimed to investigate prevalence and risk factors for colchicine side effects...
Autores principales: | SATIŞ, Hasan, ARMAĞAN, Berkan, BODAKÇI, Erdal, ATAŞ, Nuh, SARI, Alper, YAŞAR BILGE, Nazife Şule, YAPAR, Dilek, BİLİCİ SALMAN, Reyhan, YARDIMCI, Gözde Kübra, BABAOĞLU, Hakan, KILIÇ, Levent, GÖKER, Berna, HAZNEDAROĞLU, Şeminur, KAŞİFOĞLU, Timuçin, KALYONCU, Umut, TUFAN, Abdurrahman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific and Technological Research Council of Turkey
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491296/ https://www.ncbi.nlm.nih.gov/pubmed/32512676 http://dx.doi.org/10.3906/sag-2001-261 |
Ejemplares similares
-
Appendectomy history is associated with severe disease and colchicine resistance in adult familial Mediterranean fever patients
por: BODAKÇİ, Erdal, et al.
Publicado: (2021) -
Phenotypic characterization of Familial Mediterranean Fever patients harboring variants of uncertain significance
por: SARI, Alper, et al.
Publicado: (2021) -
Treatment with biologic DMARDs may not adversely affect lung nodules in rheumatoid arthritis patients
por: Karadeniz, Hazan, et al.
Publicado: (2022) -
Validity and reliability of medication adherence scale in FMF (adult version)
por: Fidanci, Berna Eren, et al.
Publicado: (2014) -
Serum ferritin as an activity marker for granulamotosis with polyangiitis
por: Kucuk, Hamit, et al.
Publicado: (2017)